Cryptocurrency listings have outperformed the average of traditional stock listings, despite recent community criticism ...

Trump's latest tariff announcement has sent tremors through the market, triggering a significant sell-off and pushing the ...

Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated ...

SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / April 4, 2025 / Jaguar Health, Inc.(NASDAQ:JAGX) ("Jaguar" or the "Company") ...

Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into ...

The listing, which includes both its primary shares on Nasdaq and its warrants on the Texas exchange, marks a significant milestone amid intensifying competition among stock exchanges. This ...

On March 12, 2025, the SEC approved a significant rule change to Nasdaq’s initial listing liquidity requirements (the New Liquidity Rules).

Health, Inc. (Nasdaq: EHTH) (ehealth.com), a leading private online health insurance marketplace (the "Company"), today announced that on April 2, 2025, the Compensation Committee of its Board of ...

Nasdaq has submitted a 19b-4 filing to the US Securities and Exchange Commission (SEC), proposing to list a spot Avalanche ...

Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people ...

NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of ...